Antithrombotic therapy in mechanical and biological prosthetic heart valves and saphenous vein bypass grafts.
D001705:Bioprosthesis / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D001026:Coronary Artery Bypass / Q000009:adverse effects*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006083:Graft Occlusion, Vascular / Q000517:prevention & control; D006801:Humans; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*
D005343:Fibrinolytic Agents